With eyes toward IND-enabling studies, TB drug startup searches for a Big Pharma partner
It’s been more than four decades since a new drug for tuberculosis has been approved by the FDA. Although Janssen is igniting hope with bedaquiline, which has been given priority review by the FDA and is set to begin late-stage trials this fall, there is still a great need for new ways to prevent and […]
